Market Research Blog

A recent market study published by FMI “Surgical Booms Market: Global Industry Analysis (2014-2018) and Opportunity Assessment (2019-2029)” consists of a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the surgical booms market, the growth prospects of the market are obtained with maximum precision. The report features the unique and salient factors that are likely to significantly impact the development of the surgical booms market during the forecast period.

Chapter 01 – Executive Summary

The report commences with the executive summary of the surgical booms market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the surgical booms market.

To Get the Sample Copy of Report visit @https://www.futuremarketinsights.com/reports/sample/rep-gb-4375

Chapter 02 – Market Overview

Readers can find the detailed taxonomy and the definition of the surgical booms market in this chapter, which will help them understand the basic information about the surgical booms market. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the surgical booms market report. The section also offers information on revenue opportunity.

Chapter 03 – Key Market Trends

The report provides key market trends that are expected to impact the market growth significantly during the forecast period. Detailed industry trends are provided in this section, along with key market development or product innovations.

Chapter 04 – Key Success Factors

This section includes the key inclusions of the report. It includes product adoption, key promotional strategies, and reimbursement scenario for market expansion.

Chapter 06 – Global Surgical Booms Market Pricing Analysis

This section highlights the average price of equipment booms, utility booms, and anesthesia booms in the different region throughout the globe. The pricing benchmark for manufacturer level pricing and distributor level pricing is analysed in this section.

Chapter 05 – Global Surgical Booms Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

This section explains the global market value analysis and forecast for the surgical booms market between the forecast periods of 2014-2029 is highlights in this section. This chapter includes the detailed analysis of the historical surgical booms market, along with an opportunity analysis of the future. Readers can also find the absolute opportunity for the current year (2019 – 2020), and an incremental opportunity for the forecast period (2019 – 2029).

Ask an Analyst @https://www.futuremarketinsights.com/ask-question/rep-gb-4375

Chapter 08 – Market Background

This chapter explains the key macro-economic factors that are expected to influence the growth of the surgical booms market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the surgical booms market. This chapter also highlights the key market dynamics of the surgical booms market, which include the drivers, restraints and trends. Moreover, readers will understand the key trends followed by the leading manufacturers in the surgical booms market.

Chapter 09 – Global Surgical Booms Market Analysis 2014 – 2018 & Forecast 2019 – 2029, By Product Type

Based on product type, the surgical booms market is segmented into four segments including, equipment booms, utility boom, anesthesia booms and custom booms. In this chapter, readers can find information about the key trends and developments in the surgical booms market and market attractiveness analysis based on the product type.

Chapter 09 – Global Surgical Booms Market Analysis 2014 – 2018 & Forecast 2019 – 2029, By Installation

Based on installation, the surgical booms market is segmented into two segments including, roof mounting and floor mounting. In this chapter, readers can find information about the key trends and developments in the surgical booms market and market attractiveness analysis based on the installation.

Chapter 10 – Global Surgical Booms Market Analysis 2014 – 2018 & Forecast, 2019 – 2029, By End User

This chapter provides details about the surgical booms market on the basis of end user, and has been classified into hospitals, ambulatory surgical centers, specialty clinics and hybrid operating rooms. In this chapter, readers can understand the market attractive analysis based on end user.

Chapter 11 – Global Surgical Booms Market Analysis 2014 – 2018 & Forecast, 2019 – 2029, By Region

This chapter explains how the surgical booms market will grow across various geographic regions, such as North America, Latin America, Europe, East Asia, South Asia, Oceania, the Middle East & Africa (MEA)

so on..

Buy this report @https://www.futuremarketinsights.com/checkout/4375

Table Of Content

1. Executive Summary

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

4. Key Success Factors

5. Global Surgical Booms Market – Pricing Analysis

so on..

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape

Ventricular Restoration Systems Market – Ventricular restoration systems offers a less invasive intervention for heart failure patients. Cardiovascular diseases are on a consistent rise in countries around the world. According to WHO, cardiovascular diseases take an estimated 17.9 million lives each year and is the no. 1 cause of death worldwide.

Von Hippel-Lindau Market – Von Hippel-Lindau is an autosomal disease can cause malignant tumor due to the mutation in the Von Hippel-Lindau gene. Von Hippel-Lindau is one of the risk factor transmitted genetically that can cause cancer. The Von Hippel-Lindau disease effects 1 in 36,000 people in the world.

Inhalational Anaesthesia Drugs Market – In patients with multiple drug allergies, inhalational anaesthesia drugs administration is considered as a safe alternative. These advantages are expected to have a positive impact on the inhalational anaesthesia drugs market.

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

FMI has conducted a study on the clinical oncology next-generation sequencing through the analysis and forecast of the clinical oncology next-generation sequencing market in its publication titled ‘Clinical Oncology Next-Generation Sequencing Market: Global Industry Analysis and Opportunity Assessment’ This report on the clinical oncology next-generation sequencing market covers the various key factors influencing the demand and supply of clinical oncology next-generation sequencing over the next several years. This report consists of the drivers, restraints, various market trends, and opportunities for participants in the clinical oncology next-generation sequencing market.

A study has been done on the various technologies of next-generation sequencing and how each technology differs from other technologies. The report consists of the ongoing trends in the market, and the various opportunities for the significant growth of the clinical oncology next-generation sequencing market.

The report consists of the various strategies adopted by the key manufacturers in the clinical oncology next-generation sequencing market. International collaborations are one of the main strategies adopted by the key manufacturers in the market. Nowadays, manufacturers are trying to develop new error-free sequencing technologies to obtain better sequencing results.

The report also focuses on the various macro-economic factors that are affecting the overall growth of the market. Some of the important macro-economic factors affecting the growth of the market include economic growth & inflation, and growing biomedical research in emerging markets. Changing biomedical and biotechnological demographics in emerging economies, such as China, India, Brazil, and South Africa, are expected to fuel the growth opportunities for medical device manufacturers. Public as well as private healthcare expenditure in these countries is expected to witness high growth, which is, in turn, expected to attract the manufacturers in these markets.

Download Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9543

The report also contains key regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa. Various trends in these regions have been covered in this report. The market attractiveness index of the products for all the regions have been covered in this report. The report also contains the market scenario of the different countries covered by each region.

The report also contains the forecast factors that impact the growth of the market. There forecast factors are expected to increase the growth of the clinical oncology next-generation sequencing market. The impact analysis of the forecast factors has been covered in the report.

The regulatory scenario for the next-generation sequencing used for oncology has been covered in this report. The profiles of various companies associated with the clinical oncology next-generation treatment market has also been included in this report, in addition to the competition landscape of various key players in the clinical oncology next-generation sequencing market.

Various key players in the clinical oncology next-generation sequencing market manufacturer several products for the sequencing of DNA. The strengths and weakness of various companies have been covered in the report.

The report also focuses on the research methodology being adopted by researchers for the estimation of the clinical oncology next-generation sequencing market in different geographies.

Global Clinical Oncology Next-Generation Sequencing Market: Segmentation

Clinical Oncology Next-Generation Sequencing Market Analysis by Product Type

• Sequencing Platforms
• Sequencing Products
• Kits and Reagents
• Services

Clinical Oncology Next-Generation Sequencing Market Analysis by Technology

• Ion Semiconductor Sequencing
• Pyro-Sequencing
• Synthesis Sequencing (SBS)
• Real Time Sequencing (SMRT)
• Ligation Sequencing
• Reversible Dye Termination Sequencing
• Nano-Pore Sequencing

Clinical Oncology Next-Generation Sequencing Market Analysis by Application

• Whole Tumor Genome Sequencing
• Whole Tumor Exome Sequencing
• Targeted Tumor Genome Profiling
• Tumor Transcriptome Sequencing
• Tumor-normal Comparisons
• Others

Clinical Oncology Next-Generation Sequencing Market Analysis by End User

• Hospital Laboratories
• Clinical Research Organizations
• Diagnostic Laboratories
• Others

Ask the Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-9543

Clinical Oncology Next-Generation Sequencing Market Analysis by Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

A recent market study published by FMI “Gene Editing Tools Market: Global Industry Analysis 2014-2018 & Forecast 2019-2029” offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the gene editing tools market, the growth prospects of the market are obtained with maximum precision.

Report Chapters

Chapter 01 – Executive Summary

The report commences with the executive summary of the gene editing tools market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the gene editing tools market.

Chapter 02 – Market Overview

Readers can find the detailed taxonomy and the definition of the gene editing tools market in this chapter, which will help them understand the basic information about the gene editing tools market. This section also highlights the key inclusions and exclusions, which helps the reader understand the scope of the gene editing tools market report.

To Get Sample Copy of Report Visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9544

Chapter 03 – Key Market Trends

The report provides the key trends that are expected to substantially impact the growth of the market during the forecast period. Detailed industry trends are provided in this section, along with key market developments or product innovations, key competition mapping, and veterinary health market outlook, which is likely to have a significant impact on gene editing tools market.

Chapter 04 – Key Success Factors

This section includes the key inclusions of the report. It includes the product adoption & usage analysis, product timeline, regulatory assessment, reimbursement scenario, pipeline assessment & opportunity analysis, and manufactures’ strategies for market expansion.

Chapter 05 – Global Gene Editing Tools Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

This section explains the global market value analysis and forecast for the gene editing tools market between the forecast period of 2014-2029. This chapter includes the detailed analysis of the historical gene editing tools market, along with an opportunity analysis of the future. Readers can also find the absolute opportunity for the current year (2019 – 2020), and an incremental opportunity for the forecast period (2019 – 2029).

Chapter 06 – Market Background

This chapter explains the key macro-economic factors that are expected to influence the growth of the gene editing tools market during the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the gene editing tools market. This chapter also highlights the key dynamics of the gene editing tools market, which include the drivers, restraints, and trends. Moreover, it will enable readers to understand the key trends followed by the leading manufacturers in the gene editing tools market.

Chapter 07 – Application of Gene Editing Tools in Emerging Areas, 2018

This section explain the global market penetration analysis for the gene editing tools in 2018. The section also covers the key information about the CRISPR patents landscape, regulatory scenario for genome editing, the adoption of CRISPR in veterinary medicine, along with the CRISPER licensing landscape. It also provides information on the penetration of the CRISPR-based gene editing tools market by emerging application areas.

Chapter 08 – Global Gene Editing Tools Market Analysis 2014 – 2018 & Forecast 2019 – 2029, By Product Type

Based on the product type, the gene editing tools market is segmented into Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9), Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), Viral Systems, transposon systems, and other gene editing tools. In this chapter, readers can find information about the key trends and developments in the gene editing tools market and market attractiveness analysis based on the product type.

Chapter 09 – Global Gene Editing Tools Market Analysis 2014 – 2018 & Forecast, 2019 – 2029, By Application

A detailed analysis about the applications of gene editing tools in the gene editing tools market has been explained in this chapter. The application areas for gene editing tools have been classified into veterinary medicine, cell-line engineering, bioremediation, food & brewing development, food waste management, biosensing development, and others. In this chapter, readers can find information about the market attractive analysis based on application.

Chapter 10 – Global Gene Editing Tools Market Analysis 2014 – 2018 & Forecast, 2019 – 2029, By End User

This chapter provides details about the gene editing tools market on the basis of end user, based on which the market has been classified into biotech & pharma companies, contract research organizations, academic & research institutes, food industry, and others. In this chapter, readers can understand the market attractiveness analysis based on end user.

Request Complete TOC of Report @ https://www.futuremarketinsights.com/reports/gene-editing-tools-market/table-of-content

Chapter 11 – Global Gene Editing Tools Market Analysis 2014 – 2018 & Forecast, 2019 – 2029, By Region

This chapter explains how the gene editing tools market will grow across various geographic regions, such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa (MEA).

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

The global demand for venous thromboembolism treatment market is likely to grow steadily over the forthcoming years. As indicated by a recent Future Market Insights (FMI) study, the market revenues will observe approximately 4% CAGR between 2019 and 2029. More than 3/5th of treatment demand is underpinned by deep venous thrombosis, according to the report. Catheter-directed thrombolysis devices and percutaneous thrombectomy devices, collectively account for more than half of the global revenues represented by the venous thromboembolism treatment market.

Venous thromboembolism treatment involves segmented pneumatic compression pumps without gradient, segmented pneumatic compression pumps with calibrated gradient, lower pneumatic compression sleeves, non-segmented pneumatic compression pumps permanent inferior vena cava filters, retrievable inferior vena cava filters, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (CDT) devices and upper pneumatic compression sleeves. Based on the disease indication, deep vein thrombosis is expected to hold a prominent share in the overall venous thromboembolism treatment market.

Download the Sample copy of Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-1341

Poor Reimbursement Scenario Against High Treatment Costs to Restrict Adoption

Several factors are impacting the overall growth of the venous thromboembolism treatment market. The first and the most important factor driving the venous thromboembolism treatment market is the increasing prevalence of venous thromboembolism disease. Other factors, such as the increasing retrieval rate of vena cava filters, increasing healthcare awareness, presence of favourable reimbursement policies, and increasing geriatric population, are also responsible for the growth of the venous thromboembolism treatment market.

Apart from the driving factors of venous thromboembolism treatment market, there are few factors that are likely to hinder the overall growth of the venous thromboembolism treatment market. The high cost associated with venous thromboembolism treatment therapy, poor reimbursement for some of the treatment devices, and poor insurance support are among the major factors that are expected to hamper the growth of the venous thromboembolism treatment market.

Preview analysis of Venous Thromboembolism Treatment Market is segmented by (Product Type – Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters, Retrievable Inferior Vena Cava Filters, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices & Catheter-Directed Thrombolysis (CDT) Devices; Disease Indication – Deep Venous Thrombosis & Pulmonary Embolism; End User – Hospitals, Catheterisation Laboratories & Ambulatory Surgical Centres;) : https://www.futuremarketinsights.com/reports/venous-thromboembolism-treatment-market

Drug-based Treatment Witnessing Traction across Europe

Although increasing preference for drug-based venous thromboembolism treatment is highly likely to hinder the growth of the market, new-generation drugs, including non-Vitamin K antagonist oral anticoagulants (NOACs) such as dabigatran, rivaroxaban, apixaban, and edoxaban, are estimated to boost the adoption rate of venous thromboembolism treatment due to increased efficacy. However, there are regional variations to this trend.

North America is expected to be a prominent region in the global venous thromboembolism treatment market because of the presence of a well-developed healthcare infrastructure and numerous technological advancements in the region. The increasing prevalence of venous thromboembolism is also responsible for the boosting the growth of the North America market. Treatment using mechanical and interventional prophylaxis systems is expected to be increasingly adopted in the North American region during the forecast period. In addition, drug-based treatment is expected to gain popularity in the European region, which is expected to subsequently decrease the usage of mechanical and interventional treatments in the region.

On the other hand, increasing per capita healthcare expenditure is one of the macroeconomic factors that is likely to boost the market. Nowadays, certain changes in the socio-economic scenario can also lead to significant growth in the venous thromboembolism treatment market.

Buy this report @ https://www.futuremarketinsights.com/checkout/1341

Tier 1 Players Account for Nearly 35% Market Revenue Share

Some of the key manufacturers of venous thromboembolism treatment are mainly focusing on innovating and launching new and advanced products. Major players in the venous thromboembolism treatment market are focusing on collaborations and acquisitions. For example, venous thromboembolism treatment is majorly adopted by hospitals, catheterisation laboratories, and ambulatory surgical centres. Hospitals are expected to hold a significant revenue share in the venous thromboembolism treatment market.

The report tracks some of the key companies operating in the venous thromboembolism treatment market such as ArjoHuntleigh AB, AngioDynamics, Cardinal Health Inc., BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, and Teleflex Inc., Boston Scientific Corp.  There are several other companies operating in the venous thromboembolism treatment market. AngioDynamics, Boston Scientific Corp., and Cardinal Health Inc. are expected to hold a prominent share in the venous thromboembolism treatment market. These tier 1 companies hold a share of approximately 35% in the venous thromboembolism treatment market.

For exclusive insights on the global and regional demand scenario of venous thromboembolism treatment, write to press@futuremarketinsights.com

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/customization-available/rep-gb-1341

According to a recently released report by Future Market Insights, widespread adoption of metagenomics tools in environmental monitoring and pollution reduction projects is estimated to boost the metagenomics market growth. Recent advancements in technology are aiding in the substantial reduction of costs incurred for sequencing paving way for the development of genetic sequencing on a large scale. This has opened up new opportunities for leveraging metagenomic tools on a large scale for monitoring of environmental microbe communities. Moreover, the efficacy of metagenomic tools in tackling environmental toxicology is further contributing to its growing popularity. For instance, a recent development saw the use of metagenomics in predicting the extent and presence of contamination in the environment while another research outlined how metagenomics can be leveraged to attenuate pollutants in the environment using unculturable microbes present in the natural environment. The use of metagenomics to understand the influence biostimulation can have on microbial communities is also under progress.

Growing concerns about environmental conditions are prompting authorities around the world to invest in researches to improve the efficiency and scale of bioremediation. In addition to this, bioremediation is gradually gaining traction owing to its cost-effective and eco-friendly chemical treatment. As metagenomics is vital to the success of bioremediation, the market is estimated to grow as the alternative chemical treatment process gains popularity.

Clinical Diagnostics to Emerge as a Vital Revenue Pocket

Clinical diagnostics and bioremediation are estimated to emerge as the highest revenue generating segments in the foreseeable future. The term metagenomic diagnostics is slowly gaining in prominence as studies experiment to widen the scope of application of metagenomics in the healthcare industry. For instance, multiple studies have alluded to the development of a new diagnostic procedure termed as “shotgun metagenomics” which uses DNA sequencing to identify different pathogens and aid in the development of effective targeted treatment by predicting their resistance against different medications. Metagenomic diagnostics presents a promising prospect that could help predict and manage the treatment of a plethora of diseases. Further, metagenomics can also potentially discover hidden genetic features that could prove vital in the progression of an assortment of biotechnological applications such as the discovery of novel enzymes, bioactive molecules, and genes with significantly better or altogether new biochemical functionalities.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-8963

Metagenomics Market Growth Underpinned by its Potential Application in Antibiotics Production

Metagenomics provides a detailed analysis of the taxonomic composition of microbe communities. It provides accurate information with regards to the gene characteristics specific to a particular community. The information provided by metagenomic tools can be effectively utilized for the production of an assortment of antibiotics. Recent research in the direction was conducted by scientists at UC Berkley who concluded leveraging metagenomics for bioprospecting soil can aid in the development of a plethora of antibiotics. The study used metagenomics to identify the genes that produce antibiotics and antifungals to combat diseases in microorganisms and stated that the same chemicals can potentially aid in combating bacterial and fungal infections in humans as well.

Library Preparation Kits find Growing Consumer Base as Gene Sequencing Gains Centerstage

DNA and RNA sequencing practices are gradually gaining traction owing to their ability to provide a massive set of valuable data about gene sequences in a small duration of time. The data generated through gene sequencing is then analysed by clinicians, scientists, and researchers who then used the derived knowledge in various verticals such as agriculture, forensics, diagnostics, pharmaceuticals, and other applications. Library preparation kits provide the means for efficient and quick extraction of gene segments which are then used for analysis. Moreover, advancements in technology are aiding library kit manufacturers in offering improved products that reduce error and stress while improving accuracy. The FMI report opines the factors will prove vital in the growth of the segment which is estimated to contribute significantly to the metagenomics market growth.

Metagenomics Market Continues to Propel in North America, Upheld by Government Funding for Epigenetics R&D

The FMI study opines metagenomics market in North America is estimated to continue to proliferate and remain at the helm of the global metagenomics market growth. Presence of advanced infrastructure coupled with continuous government funding for research and development in the field of epigenetics are the vital factors that are estimated to drive the growth of the market in the region. Further, the presence of favorable regulations promoting research and development for improving the quality of healthcare in the countries in the region are expected to fuel the market growth.

Metagenomics Market – Segmentation

On the basis of product type

• sample extraction kits
• metagenomics sequencing kits
• library preparation kits

On the basis of application

• bioremediation
• microbial diversity
• antibiotics production
• clinical diagnostics
• biosurfactants

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-8963

On the basis of end-use industry

• hospitals
• academics and research
• pharmaceutical industries
• research laboratories
• others
  • emergency services
  • clinics.

According to a study of Future Market Insights (FMI), anemia treatment market will surpass US$ 7.8 billion in 2019. More than 70% of the anemia treatment is sought for normocytic anemia, followed by microcytic anemia. Most of the demand for anemia treatment is driven by the condition as a result of one or more chronic diseases, according to a new research study by Future Market Insights.